CRISPR THERAPEUTICS AG Foreign Currency Transaction Gain (Loss), Unrealized
CRISPR THERAPEUTICS AG (CRSP) reported Foreign Currency Transaction Gain (Loss), Unrealized of $9.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2019-02-25
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for the quarter ending 2017-12-31 was $0.00.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for the quarter ending 2017-06-30 was $10.00K.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for the quarter ending 2017-03-31 was -$1.00K.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for fiscal 2017 was $9.00K.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for fiscal 2016 was -$2.00K, a 110.00% decline from fiscal 2015.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for fiscal 2015 was $20.00K, a 92.31% decline from fiscal 2014.
- CRISPR THERAPEUTICS AG foreign currency transaction gain (loss), unrealized for fiscal 2014 was $260.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $0.00 derived: sum of 2 quarters · filed 2019-02-25 | $10.00K derived: sum of 3 quarters · filed 2019-02-25 | $9.00K 10-K · filed 2019-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $10.00K derived: sum of 2 quarters · filed 2018-11-07 | $9.00K 10-Q · filed 2018-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $9.00K 10-Q · filed 2018-08-07 | $0.00 derived: sum of 3 quarters · filed 2019-02-25 | $21.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$1.00K 10-Q · filed 2018-05-08 | -$10.00K derived: sum of 2 quarters · filed 2019-02-25 | $11.00K derived: sum of 3 quarters · filed 2019-02-25 | $8.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $12.00K derived: sum of 2 quarters · filed 2019-02-25 | $9.00K derived: sum of 3 quarters · filed 2019-02-25 | -$2.00K 10-K · filed 2019-02-25 |
| 2016-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $18.00K derived: sum of 2 quarters · filed 2017-11-08 | $7.00K 10-Q · filed 2017-11-08 | -$72.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$14.00K 10-Q · filed 2017-08-10 | -$93.00K derived: sum of 3 quarters · filed 2018-03-08 | |
| 2016-03-31 | -$11.00K 10-Q · filed 2017-05-11 | -$90.00K derived: sum of 2 quarters · filed 2018-03-08 | ||
| 2015-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $20.00K 10-K · filed 2018-03-08 | ||
| 2015-09-30 | $99.00K 10-Q · filed 2016-11-22 | |||
| 2014-12-31 | $260.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |